Mayet Mayet
Product Blog Resources About
Contact Us
  1. Blog
  2. Author: Tom Lazenby
  3. Page 4
  • The Sponsor’s Guide: Record Keeping for Vendor Oversight Compliance

    Dec 20, 2023

    —

    by

    Tom Lazenby
    in General
    The Sponsor’s Guide: Record Keeping for Vendor Oversight Compliance

    Vendor management and meticulous record-keeping are paramount for Sponsors, as they navigate through the web of regulatory compliance and ensure the seamless conduct of trials. Importance of Record Keeping in Vendor Management Clinical Trial Sponsors, tasked responsibility of overseeing successful, efficient and compliant clinical trials, need to implement a meticulous and centralised record-keeping system throughout…

    Read more »: The Sponsor’s Guide: Record Keeping for Vendor Oversight Compliance
  • 5 Common Pitfalls in Risk Identification and How to Avoid Them

    Dec 13, 2023

    —

    by

    Tom Lazenby
    in General
    5 Common Pitfalls in Risk Identification and How to Avoid Them

    Risk identification in clinical trials is a proactive and ongoing process of systematically detecting, documenting, and assessing potential threats that could hinder the progress, integrity, or outcomes of a trial, setting the foundation for subsequent risk management activities. For clinical trial managers and clinical quality assurance managers, risk management is not just an optional add-on…

    Read more »: 5 Common Pitfalls in Risk Identification and How to Avoid Them
  • Vendor Oversight and Data Integrity

    Dec 6, 2023

    —

    by

    Tom Lazenby
    in General
    Vendor Oversight and Data Integrity

    This blog post explores the meaning of data integrity governed by the stringent ALCOA++ principles, and how this is maintained through robust vendor oversight practices and achieves regulatory compliance. From the initial vendor qualification process to data collection, processing, and reporting, each step is dissected to provide a clear understanding of the importance of setting…

    Read more »: Vendor Oversight and Data Integrity
  • GCP Principles and Vendor Management

    Nov 29, 2023

    —

    by

    Tom Lazenby
    in General
    GCP Principles and Vendor Management

    Understanding all the requirement of clinical trials necessitates a strong knowledge of the Good Clinical Practice (GCP) principles as laid out in the International Council for Harmonisation’s (ICH) E6 guidelines. These principles are the bedrock of ethical and efficient clinical trial management. When it comes to vendor management, aligning specific GCP sections with corresponding vendor…

    Read more »: GCP Principles and Vendor Management
  • GCP Non-Compliance in Vendor Management

    Nov 22, 2023

    —

    by

    Tom Lazenby
    in General
    GCP Non-Compliance in Vendor Management

    Good Clinical Practice (GCP) non-compliance in vendor management is an area that requires strict attention from sponsors and trial managers. This blog post will guide you through: The GCP guidelines are upheld in law and by regulatory bodies such as: Non-compliance with GCP can occur in various aspects of vendor management, ranging from inadequate record…

    Read more »: GCP Non-Compliance in Vendor Management
  • The Fire Triangle: Part 3 – Data Applications in Vendor Management

    Nov 15, 2023

    —

    by

    Tom Lazenby
    in General
    The Fire Triangle: Part 3 – Data Applications in Vendor Management

    Clinical Trial Vendor Management presents challenges that are complex, at the core of this, data emerges, offering clarity and direction. As we continue into the final segment of our Fire Triangle blog post series, it’s time to dive into the role data plays in robust vendor management strategies. Every decision, strategy and every outcome hinges…

    Read more »: The Fire Triangle: Part 3 – Data Applications in Vendor Management
  • The Fire Triangle: Part 2 Expert Communication

    Nov 9, 2023

    —

    by

    Tom Lazenby
    in General
    The Fire Triangle: Part 2 Expert Communication

    In Clinical Trial Vendor Management, communication is the oxygen, facilitating every process and enabling a seamless flow of data. Diving into the Fire Triangle’s second pillar, let’s explore the importance of effective Communication, focusing on its three primary components: Escalation, Expectations, and change management.

    Read more »: The Fire Triangle: Part 2 Expert Communication
  • Fire Triangle: Part 1 Process Playbook

    Nov 1, 2023

    —

    by

    Tom Lazenby
    in General
    Fire Triangle: Part 1 Process Playbook

    The intricacies of Clinical Trial Vendor Management are woven into a series of processes, these processes are managed and delivered by different people within the organisation and are often performed simultaneously in multi-disciplinary teams, so how do we ensure consistency and quality in delivery of the process? Errors in conduct of these processes throughout the…

    Read more »: Fire Triangle: Part 1 Process Playbook
  • Introduction to the Fire Triangle of Clinical Trial Vendor Management

    Oct 25, 2023

    —

    by

    Tom Lazenby
    in General
    Introduction to the Fire Triangle of Clinical Trial Vendor Management

    Managing vendors in clinical trials is a fine balance of several critical elements. For many in the industry, understanding these elements’ significance and interplay can be complex. That’s where the analogy of the Fire Triangle comes in handy. Just as fire needs oxygen, heat, and fuel to ignite, robust vendor management in clinical trials depends…

    Read more »: Introduction to the Fire Triangle of Clinical Trial Vendor Management
  • 4 Common Regulatory Challenges in Clinical Trials Vendor Management and Oversight

    Oct 18, 2023

    —

    by

    Tom Lazenby
    in General
    4 Common Regulatory Challenges in Clinical Trials Vendor Management and Oversight

    Clinical trials, come with their own unique set of regulatory challenges. This is a technical challenge when navigating vendor management and oversight. As with many challenges with moving parts, the devil is often in the details. In this blog post we’ll hit on four of these challenges and offer insight into how clinical quality, clinical…

    Read more »: 4 Common Regulatory Challenges in Clinical Trials Vendor Management and Oversight
←Previous Page Next Page→

Search

Topics

  • General

Latest Posts

  • Mayet Goes Modular!
  • Integration Partnership with PHARMASEAL CTMS
  • Mayet Strengthens Quality Leadership with Addition of New Strategic Advisor
  • 8 Transformative ICH E6(R3) Service Provider Management Requirements
  • The Human Side of Clinical Trial Quality
  • Mayet Strengthens Commercial Leadership with Addition New Strategic Advisor
  • Vendor Risk Management: A Modern Approach

Footer

Mayet

Mayet Solutions Ltd
London, W1W 5PF
United Kingdom

Phone: +44 792 012 2927

LinkedIn

Mayet Software

  • Product
  • Request Demo

Resources

  • Briefing
  • Webinar
  • GCP R3 Seminar
  • White Paper
  • Resources

Company

  • Blog
  • Contact
  • About
  • Security & Compliance
  • Legal

© 2023-2024 Mayet Solutions Ltd – All rights reserved

Cyber Essentials Insurance Cyber Essentials Plus Certified